HB 1169
Signed
classify medetomidine as a Schedule III controlled substance and establish permissible uses.
- South Dakota
- House / Assembly
- Introduced Jan 28, 2026
- Session 2026
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
South Dakota’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
14 actions-
Signed by the Governor on 2026-03-09 H.J. 534
-
Delivered to the Governor on 2026-03-04 H.J. 497
-
Signed by the President S.J. 448
-
Signed by the Speaker H.J. 477
-
Senate Do Pass , Passed, YEAS 32, NAYS 0 S.J. 412
-
Certified uncontested, placed on consent , Passed, S.J. 21
-
Health and Human Services Do Pass , Passed, YEAS 7, NAYS 0 S.J. 21
-
Scheduled for hearing S.J. 1
-
First read in Senate and referred to Senate Health and Human Services S.J. 260
-
House of Representatives Do Pass , Passed, YEAS 63, NAYS 3 H.J. 295
-
Certified uncontested, placed on consent , Passed,
-
Health and Human Services Do Pass , Passed, YEAS 11, NAYS 0
-
Scheduled for hearing
-
First read in House and referred to House Health and Human Services H.J. 163